Brain tumors in children at one hospital in Nigeria over 14 years
Original title: Paediatric Primary Intracranial Tumours: A 14-year Clinicopathologic Study in North-Central Nigeria.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This looked back at records of children, and it did not test a treatment.
The short version
Doctors in Nigeria looked back at the records of children with brain tumors to learn which kinds were most common.
What was studied. Doctors looked back at the records of children aged 0-17 years. These children had brain tumors found at one hospital in Jos, Nigeria, over a 14-year period. The doctors noted each child's age, sex, tumor type, tumor grade, tumor location, and first signs.
What they found. The children were from 6 weeks to 17 years old. The most common age group was 0-4 years, at 30.8%, and slightly more girls than boys had tumors. The most common tumor was pilocytic astrocytoma, at 23.1%, then medulloblastoma, at 15.4%. Most tumors were slower-growing, low-grade tumors, at 73.1%, and 26.9% were faster-growing, high-grade tumors. Headache was the most common first sign, at 67.3%. Next came trouble seeing, at 30.8%, and trouble walking, at 26.9%.
What this means, and what it doesn't
What it could mean: Brain tumors in children at this hospital looked much like those seen in other places. Headache, trouble seeing, and trouble walking were common early signs. The doctors say better testing tools and more teamwork in research are needed to help children do better.
What it doesn't mean: This study did not test any treatment. It only looked back at past records from one hospital. It does not change how any child is treated today. It is not a cure or a promise of one.
Source: PubMed, September 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.